Chalfont St. Peter, United Kingdom

Delme Evans

This inventor holds 13 USPTO granted patents. Top assignees: Lilly Industries, Inc., Eli Lilly and Company, Eli Lilly Industries Limited. Active years: 1976-1980.


% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 87(Granted Patents)


Location History:

  • Peter, EN (1977)
  • Chalfont St. Peter, EN (1976 - 1978)
  • Peter, GB (1978)
  • Chalfont St. Peter, GB (1978 - 1980)

Company Filing History:


Years Active: 1976-1980

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Delme Evans: Innovator in Pharmaceutical Compounds

Introduction

Delme Evans is a notable inventor based in Chalfont St. Peter, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-allergy activity. With a total of 13 patents to his name, Evans has established himself as a key figure in innovation.

Latest Patents

Among his latest patents are the acylamino furan derivatives and acylamino heteroaryl compounds. These compounds feature a 5-membered ring containing a single heteroatom, which may be oxygen or sulfur. The methods of making these compounds and the pharmaceutical formulations containing them are also part of his innovative work. The compounds developed by Evans are recognized for their anti-allergy activity, showcasing his commitment to addressing health challenges.

Career Highlights

Evans has worked with prominent companies in the pharmaceutical industry, including Lilly Industries, Inc. and Eli Lilly and Company. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Throughout his career, Delme Evans has collaborated with notable individuals such as David William Dunwell and Terence Alan Hicks. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Delme Evans is a distinguished inventor whose work in pharmaceutical compounds has made a significant impact in the field. His innovative contributions continue to advance the development of effective anti-allergy treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…